期刊文献+

第一代和第二代组胺H_1受体拮抗剂对大鼠戊四唑点燃癫痫形成过程的作用比较 被引量:2

Effects between the first-and second-generation histamine H_1-antagonists on seizure development of pentylenetetrazole -induced kindling in rats
暂未订购
导出
摘要 目的 :比较第一代组胺 H1受体拮抗剂苯海拉明和第二代拮抗剂索非那丁对大鼠戊四唑点燃癫痫形成过程的作用 ,并初步探讨其作用机制。方法 :大鼠隔日腹腔先注射不同代的 H1受体拮抗剂和 /或组氨酸 ,后注射亚惊厥剂量 ( 35 mg/ kg)的戊四唑 ,诱发化学性点燃癫痫 ,观察并比较各组每次戊四唑注射后 30 min内癫痫发作的行为变化。用荧光法测定脑内组胺含量。结果 :与对照组相比 ,苯海拉明 ( 5 mg/ kg)明显加速大鼠戊四唑化学点燃 ,而索非那丁 ( 5 mg/ kg)则不影响大鼠戊四唑点燃过程 ;苯海拉明加速戊四唑点燃的作用可被组胺的前体物质组氨酸所拮抗。结论 :第一代组胺 H1受体拮抗剂通过阻断脑内组胺 H1受体促进了戊四唑化学性点燃的形成 ,第二代组胺H1受体拮抗剂由于很难进入血脑屏障而无此作用。 Objective: To investigate the effects and the mechanisms of the first-generation histamine H 1-antagonist diphenhydramine and the second-generation histamine H 1-antagonist fexofenadine on seizure development of pentylenetetrazole (PTZ)-induced kindling in rats. Methods: The first- or second-generation histamine H 1-antagonists and/or histidine were ip injected in rats every 48 h, followed by a subconvulsive dose of PTZ (35 mg/kg). Then the behavioral changes were observed for 30 min after every injection of PTZ. The histamine content of brain was measured spectrofluorometrically. Results: Compared with the control group, diphenhydramine (5 mg/kg) significantly augmented the severity of seizure development of PTZ-induced kindling, whereas fexofenadine (5 mg/kg) had no marked influence. The effects of diphenhydramine were antagonized by histidine, the precursor of histamine. Conclusion: Seizure development of PTZ-induced kindling is promoted by the first- but not the second-generation histamine H 1-antagonists via the blockade of brain histamine H 1-receptor.
出处 《浙江大学学报(医学版)》 CAS CSCD 2004年第3期209-212,共4页 Journal of Zhejiang University(Medical Sciences)
基金 国家自然科学基金( 30 3716 38) 浙江省青年人才基金(R30 3779)资助项目
关键词 癫痫/化学诱导 疾病模型 动物 大鼠 苯海拉明/药理学 索非那丁/药理学 Epilepsy/chem ind Disease models,animal Rats Diphenhydramine/pharmacol Fexofenadine/pharmacol
  • 相关文献

参考文献1

二级参考文献18

  • 1MARKHAM A, WAGSTAFF AJ. fexofenadine[J]. Drugs, 1998,55(2):269-274 .
  • 2NACLERIO RM. All allergic rhinitis[J]. N Engl J Med,1991,325(12):860-8 69.
  • 3PHILPOT EE. Safety of second generation antihistamines[J]. Allergy Ast hma Proc,2000,21(1):15-21.
  • 4MONAHAN BP, FERGUSON CL, KILLEAVY ES. Torsade pointers occurring in assoc iation with terfenadine use[J]. JAMA, 1990,264(21):2788-2790.
  • 5GUPTAA K, KATZ HI, SHEAR NH. Drug interactions with intraconazole, fluco nazole and terbinafine and their management[J]. J Am Acad Dermatol, 1999,412 P t 1:237-249.
  • 6SLATER JW, ZECHNICH AD, HARBY DG. Second-generation antihistamine: a comp arative review[J]. Drugs,1999,57(1):31-47.
  • 7LINDQUIST M, EDWARDS IR. Risk of non-sedating antihistamine[J]. Lancet ,1997,349(9061):1322.
  • 8RANKIN AC. Non-Sedating antihistamines and cardiac arrhythmia[J]. Lance t,1997,350(9085):1115-1116.
  • 9HONIG PK, WORTHAN DC, ZAMANI K, et al. Terfenadine-Ketoconazole int eraction[J]. JAMA, 1993,269(12):1513-1518.
  • 10HONIG PK, WOOSLEY RL, ZAMAIN K. Changes in the pharmacokinetics and elec trocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin[J]. Clin Pharmacol Ther,1992,51(2):231-238.

共引文献10

同被引文献22

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部